Acura Pharmaceuticals (ACUR +47.9%) shares skyrocket ~50%, apparently due to a report from EMPR.com that its Nexafed drug will be available soon. Nexafed is an immediate-release next generation pseudoephedrine tablet which combines nasal congestion relief with ACUR's IMPEDE technology that disrupts the conversion of pseudoephedrine into methamphetamine.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs